Compare SUPN & UTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SUPN | UTF |
|---|---|---|
| Founded | 2005 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.4B |
| IPO Year | 2012 | N/A |
| Metric | SUPN | UTF |
|---|---|---|
| Price | $45.59 | $24.56 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $63.25 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 171.7K |
| Earning Date | 11-04-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.19% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 2.84 |
| Revenue | ★ $681,539,000.00 | $138,636,669.00 |
| Revenue This Year | $8.29 | N/A |
| Revenue Next Year | $22.72 | N/A |
| P/E Ratio | ★ N/A | $9.16 |
| Revenue Growth | 4.54 | ★ 19.80 |
| 52 Week Low | $29.16 | $22.05 |
| 52 Week High | $57.65 | $26.53 |
| Indicator | SUPN | UTF |
|---|---|---|
| Relative Strength Index (RSI) | 43.24 | 61.35 |
| Support Level | $44.37 | $23.43 |
| Resistance Level | $47.00 | $24.08 |
| Average True Range (ATR) | 1.56 | 0.30 |
| MACD | -0.02 | 0.09 |
| Stochastic Oscillator | 55.51 | 97.17 |
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
Cohen & Steers Infrastructure Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is total return with an emphasis on income. It invests majority of its managed assets in securities issued by infrastructure companies, which consists of utilities, pipelines, toll roads, airports, railroads, ports, telecommunications companies, and other infrastructure companies, under normal market conditions.